Durect Corporation (DRRX) - Net Assets

Latest as of June 2025: $3.94 Million USD

Based on the latest financial reports, Durect Corporation (DRRX) has net assets worth $3.94 Million USD as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($12.48 Million) and total liabilities ($8.54 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Durect Corporation to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets $3.94 Million
% of Total Assets 31.54%
Annual Growth Rate -3.23%
5-Year Change -77.24%
10-Year Change -38.65%
Growth Volatility 211.02

Durect Corporation - Net Assets Trend (1999–2024)

This chart illustrates how Durect Corporation's net assets have evolved over time, based on quarterly financial data. Also explore DRRX total assets for the complete picture of this company's asset base.

Annual Net Assets for Durect Corporation (1999–2024)

The table below shows the annual net assets of Durect Corporation from 1999 to 2024. For live valuation and market cap data, see Durect Corporation market capitalisation.

Year Net Assets Change
2024-12-31 $9.13 Million -38.23%
2023-12-31 $14.78 Million -40.83%
2022-12-31 $24.98 Million -56.76%
2021-12-31 $57.78 Million +44.04%
2020-12-31 $40.12 Million +75.48%
2019-12-31 $22.86 Million +14.30%
2018-12-31 $20.00 Million -6.92%
2017-12-31 $21.49 Million +157.71%
2016-12-31 $8.34 Million -43.98%
2015-12-31 $14.88 Million -19.62%
2014-12-31 $18.52 Million -39.73%
2013-12-31 $30.72 Million -15.44%
2012-12-31 $36.33 Million +944.90%
2011-12-31 $3.48 Million -76.00%
2010-12-31 $14.49 Million -47.16%
2009-12-31 $27.42 Million -24.72%
2008-12-31 $36.42 Million +5.32%
2007-12-31 $34.58 Million -6.62%
2006-12-31 $37.03 Million -14.58%
2005-12-31 $43.35 Million +135.74%
2004-12-31 $18.39 Million -59.24%
2003-12-31 $45.12 Million -31.83%
2002-12-31 $66.18 Million -31.80%
2001-12-31 $97.05 Million -15.80%
2000-12-31 $115.25 Million +456.03%
1999-12-31 $20.73 Million --

Equity Component Analysis

This analysis shows how different components contribute to Durect Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 58669800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $23.00K 0.25%
Other Comprehensive Income $-1.00K -0.01%
Other Components $606.44 Million 6641.54%
Total Equity $9.13 Million 100.00%

Durect Corporation Competitors by Market Cap

The table below lists competitors of Durect Corporation ranked by their market capitalization.

Company Market Cap
Amiad Water Systems Ltd
TA:AMD
 $59.32 Million
Everspring Industry Co Ltd
TW:2390
 $59.35 Million
Equus Energy Ltd
AU:EQU
 $59.37 Million
Inta Bina Group Bhd
KLSE:0192
 $59.42 Million
Alliance Witan Ord
LSE:ALW
 $59.31 Million
Global Mofy Metaverse Limited Ordinary Shares
NASDAQ:GMM
 $59.31 Million
Cepatwawasan Group Bhd
KLSE:8982
 $59.31 Million
Manba Finance Ltd
NSE:MANBA
 $59.30 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Durect Corporation's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 14,783,000 to 9,131,000, a change of -5,652,000 (-38.2%).
  • Net loss of 8,324,000 reduced equity.
  • New share issuances of 648,000 increased equity.
  • Other comprehensive income increased equity by 13,000.
  • Other factors increased equity by 2,011,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-8.32 Million -91.16%
Share Issuances $648.00K +7.1%
Other Comprehensive Income $13.00K +0.14%
Other Changes $2.01 Million +22.02%
Total Change $- -38.23%

Book Value vs Market Value Analysis

This analysis compares Durect Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 6.47x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 0.30x to 6.47x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1999-12-31 $6.30 $1.91 x
2000-12-31 $34.87 $1.91 x
2001-12-31 $20.91 $1.91 x
2002-12-31 $13.70 $1.91 x
2003-12-31 $8.93 $1.91 x
2004-12-31 $3.57 $1.91 x
2005-12-31 $8.07 $1.91 x
2006-12-31 $5.61 $1.91 x
2007-12-31 $4.91 $1.91 x
2008-12-31 $4.65 $1.91 x
2009-12-31 $3.29 $1.91 x
2010-12-31 $1.67 $1.91 x
2011-12-31 $0.40 $1.91 x
2012-12-31 $4.10 $1.91 x
2013-12-31 $2.98 $1.91 x
2014-12-31 $1.66 $1.91 x
2015-12-31 $1.26 $1.91 x
2016-12-31 $0.63 $1.91 x
2017-12-31 $1.48 $1.91 x
2018-12-31 $1.25 $1.91 x
2019-12-31 $1.28 $1.91 x
2020-12-31 $2.01 $1.91 x
2021-12-31 $2.57 $1.91 x
2022-12-31 $1.10 $1.91 x
2023-12-31 $0.56 $1.91 x
2024-12-31 $0.30 $1.91 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Durect Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -91.16%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -409.85%
  • • Asset Turnover: 0.11x
  • • Equity Multiplier: 2.01x
  • Recent ROE (-91.16%) is above the historical average (-113.78%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1999 -42.01% -10125.58% 0.00x 1.08x $-10.78 Million
2000 -17.22% -629.19% 0.03x 1.05x $-31.38 Million
2001 -46.29% -688.66% 0.06x 1.08x $-54.63 Million
2002 -56.17% -517.37% 0.10x 1.10x $-43.79 Million
2003 -50.31% -191.79% 0.11x 2.49x $-27.21 Million
2004 -150.28% -199.50% 0.16x 4.65x $-29.48 Million
2005 -41.82% -63.45% 0.24x 2.71x $-22.46 Million
2006 -90.00% -152.22% 0.21x 2.77x $-37.03 Million
2007 -70.38% -79.34% 0.37x 2.43x $-27.80 Million
2008 -123.70% -173.56% 0.35x 2.06x $-48.69 Million
2009 -112.03% -126.44% 0.42x 2.12x $-33.46 Million
2010 -158.06% -72.48% 0.47x 4.66x $-24.35 Million
2011 -539.69% -56.04% 0.68x 14.15x $-19.11 Million
2012 44.59% 30.53% 1.16x 1.26x $12.57 Million
2013 -69.83% -139.97% 0.38x 1.33x $-24.52 Million
2014 -119.42% -113.96% 0.39x 2.71x $-23.96 Million
2015 -152.27% -118.51% 0.41x 3.14x $-24.15 Million
2016 -413.88% -246.05% 0.35x 4.86x $-35.34 Million
2017 -17.20% -7.51% 0.93x 2.47x $-5.84 Million
2018 -126.61% -136.40% 0.37x 2.50x $-27.32 Million
2019 -90.02% -69.60% 0.34x 3.76x $-22.86 Million
2020 -33.47% -44.59% 0.40x 1.89x $-17.44 Million
2021 -62.76% -259.46% 0.15x 1.59x $-42.04 Million
2022 -141.42% -183.23% 0.32x 2.41x $-37.83 Million
2023 -186.86% -323.16% 0.19x 3.06x $-29.10 Million
2024 -91.16% -409.85% 0.11x 2.01x $-9.24 Million

Industry Comparison

This section compares Durect Corporation's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $236,113,024
  • Average return on equity (ROE) among peers: -47.06%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Durect Corporation (DRRX) $3.94 Million -42.01% 2.17x $59.31 Million
Aurora Cannabis Inc (ACB) $602.92 Million -11.50% 0.39x $197.35 Million
Akanda Corp (AKAN) $-3.83 Million 0.00% 0.00x $1.51 Million
Akebia Ther (AKBA) $74.01 Million -330.87% 6.15x $340.21 Million
Alkermes Plc (ALKS) $54.20 Million -73.99% 0.03x $4.62 Billion
Amylyx Pharmaceuticals Inc (AMLX) $-25.36 Million 0.00% 0.00x $1.77 Billion
Amphastar P (AMPH) $639.42 Million 21.51% 1.37x $959.02 Million
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) $346.79 Million -104.36% 9.57x $3.81 Billion
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) $344.93 Million 26.40% 10.61x $3.57 Billion
Anika Therapeutics Inc (ANIK) $287.08 Million 1.44% 0.21x $199.00 Million
ANI Pharmaceuticals Inc (ANIP) $40.96 Million 0.73% 0.09x $1.80 Billion

About Durect Corporation

NASDAQ:DRRX USA Drug Manufacturers - Specialty & Generic
Market Cap
$59.31 Million
Market Cap Rank
#21234 Global
#4537 in USA
Share Price
$1.91
Change (1 day)
-1.04%
52-Week Range
$0.50 - $1.96
All Time High
$38.00
Categories
Companies in USA Drug Manufacturers - Specialty & Generic
About

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product candidate includes larsucosterol, an endogenous, orally bioavailable small molecule to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as for the treatment… Read more